Competitor Analysis: Ras-Raf-MEK-ERK InhibitorsLa Merie PublishingJune 1, 2011 75 Pages - SKU: LAM6404209 |
- Index
- Ras Inhibitors
- Selective RAF Inhibitors
- Dual RAF and MEK Inhibitors
- Dual RAF and PI3K Inhibitors
- Other Dual RAF Inhibitors
- Multi RTK Inhibitors including RAF Inhibition
- MEK Inhibitors
- ERK Inhibitors
- Other Inhibitors of the Ras-RAF-MEK-ERK Pathway
- Corporate Ras-Raf-MEK-ERK Inhibitor R&D Pipelines
- About La Merie
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Drug Discovery Reports
- Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer’s Disease
- Central Nervous System Disorder Drugs Markets in China
- Lymphoma Treatment Drugs Markets in China
- Anti-Tumor Drugs Markets in China
- Osteoporosis Treatment Drugs Markets in China